These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 8891588)

  • 1. Stimulating dopamine D1 receptors increases the locomotor activity of developing rats.
    Shieh GJ; Walters DE
    Eur J Pharmacol; 1996 Sep; 311(2-3):103-7. PubMed ID: 8891588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective dopamine antagonist pretreatment on the antiparkinsonian effects of benzazepine D1 dopamine agonists in rodent and primate models of Parkinson's disease--the differential effects of D1 dopamine antagonists in the primate.
    Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1995 Feb; 117(4):403-12. PubMed ID: 7604140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catalepsy-associated behavior induced by dopamine D1 receptor antagonists and partial dopamine D1 receptor agonists in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    Eur J Pharmacol; 1994 Aug; 260(2-3):237-41. PubMed ID: 7988649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biphasic locomotor effects of the dopamine D1 agonist SKF 38393 and their attenuation in non-habituated mice.
    Tirelli E; Terry P
    Psychopharmacology (Berl); 1993; 110(1-2):69-75. PubMed ID: 7870901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SKF 83959 is an antagonist of dopamine D1-like receptors in the prefrontal cortex and nucleus accumbens: a key to its antiparkinsonian effect in animals?
    Cools AR; Lubbers L; van Oosten RV; Andringa G
    Neuropharmacology; 2002 Feb; 42(2):237-45. PubMed ID: 11804620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
    Wirtshafter D; Osborn CV
    Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained extracellular signal-regulated kinase 1/2 phosphorylation in neonate 6-hydroxydopamine-lesioned rats after repeated D1-dopamine receptor agonist administration: implications for NMDA receptor involvement.
    Papadeas ST; Blake BL; Knapp DJ; Breese GR
    J Neurosci; 2004 Jun; 24(26):5863-76. PubMed ID: 15229233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice.
    Ralph RJ; Caine SB
    J Pharmacol Exp Ther; 2005 Feb; 312(2):733-41. PubMed ID: 15494551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parametric and pharmacological analyses of the enhanced grooming response elicited by the D1 dopamine receptor agonist SKF 38393 in the rat.
    Wachtel SR; Brooderson RJ; White FJ
    Psychopharmacology (Berl); 1992; 109(1-2):41-8. PubMed ID: 1365670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the effects of the D1 receptor antagonists SCH 23390 and SCH 39166 on suppression of feeding behavior by the D1 agonist SKF38393.
    Terry P; Katz JL
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):328-33. PubMed ID: 7862841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Place conditioning with the dopamine D1-like receptor agonist SKF 82958 but not SKF 81297 or SKF 77434.
    Abrahams BS; Rutherford JD; Mallet PE; Beninger RJ
    Eur J Pharmacol; 1998 Feb; 343(2-3):111-8. PubMed ID: 9570457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
    Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M
    Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased striatal dopamine efflux after intrastriatal application of benzazepine-class D1 agonists is not mediated via dopamine receptors.
    Zackheim JA; Abercrombie ED
    Brain Res Bull; 2001 Apr; 54(6):603-7. PubMed ID: 11403986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of both dopamine D1 and D2 receptors necessary for amelioration of conditioned fear stress.
    Kamei H; Kameyama T; Nabeshima T
    Eur J Pharmacol; 1995 Feb; 273(3):229-33. PubMed ID: 7737329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for the sensitivity of operant timing behaviour to stimulation of D1 dopamine receptors.
    Cheung TH; Bezzina G; Hampson CL; Body S; Fone KC; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2007 Dec; 195(2):213-22. PubMed ID: 17668188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of D1, but not D2 receptors potentiates dizocilpine-mediated disruption of prepulse inhibition of the startle.
    Bortolato M; Aru GN; Fà M; Frau R; Orrù M; Salis P; Casti A; Luckey GC; Mereu G; Gessa GL
    Neuropsychopharmacology; 2005 Mar; 30(3):561-74. PubMed ID: 15328529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topographical resolution of jaw movements mediated by cyclase- vs. non-cyclase-coupled dopamine D(1)-like receptors: studies with SK&F 83822.
    Fujita S; Lee J; Kiguchi M; Uchida T; Cools AR; Waddington JL; Koshikawa N
    Eur J Pharmacol; 2006 May; 538(1-3):94-100. PubMed ID: 16682023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates.
    Byrnes EM; Bruno JP
    Dev Psychobiol; 1994 Sep; 27(6):409-24. PubMed ID: 8001729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Existence of dopamine D1 receptor on the sympathetic nerve endings in the guinea-pig vas deferens.
    Furukawa T; Morishita H
    Eur J Pharmacol; 1997 Jun; 328(2-3):229-34. PubMed ID: 9218705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
    Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.